Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory D Sempowski

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
Frontiers in Public Health|April 11, 2025
Use of a pathogen X tabletop exercise to assess the operational response preparedness of an emerging infectious diseases research networkRachael Lee, Jennifer Hemingway-Foday, Nefer Batsuli, et al.
Rheumatology (Oxford, England)|February 2, 2022
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapyAnkoor Shah, Jan Storek, Rob Woolson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2023
The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primatesW June Brickey, David L Caudell, Andrew N Macintyre, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in miceDavid R Martinez, Alexandra Schaefer, Sophie Gobeil, et al.
Science (New York, N.Y.)|October 30, 2020
Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolitesHao Guo, Wei-Chun Chou, Yunjia Lai, et al.
Science Advances|June 26, 2021
Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care testJacob T Heggestad, David S Kinnamon, Lyra B Olson, et al.
BMJ Global Health|June 4, 2025
Importance of outbreak response research in bridging knowledge gaps on emerging infectious diseasesRobert F Breiman, Eric Osoro, Richard Reithinger, et al.
Scientific Reports|July 9, 2022
Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversionNicholas S Giroux, Shengli Ding, Micah T McClain, et al.
Scientific Reports|April 20, 2023
Author Correction: Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversionNicholas S Giroux, Shengli Ding, Micah T McClain, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trialsJill Whitley, Christopher Zwolinski, Christian Denis, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
Frontiers in Public Health|April 11, 2025
Use of a pathogen X tabletop exercise to assess the operational response preparedness of an emerging infectious diseases research networkRachael Lee, Jennifer Hemingway-Foday, Nefer Batsuli, et al.
Rheumatology (Oxford, England)|February 2, 2022
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapyAnkoor Shah, Jan Storek, Rob Woolson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2023
The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primatesW June Brickey, David L Caudell, Andrew N Macintyre, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in miceDavid R Martinez, Alexandra Schaefer, Sophie Gobeil, et al.
Science (New York, N.Y.)|October 30, 2020
Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolitesHao Guo, Wei-Chun Chou, Yunjia Lai, et al.
Science Advances|June 26, 2021
Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care testJacob T Heggestad, David S Kinnamon, Lyra B Olson, et al.
BMJ Global Health|June 4, 2025
Importance of outbreak response research in bridging knowledge gaps on emerging infectious diseasesRobert F Breiman, Eric Osoro, Richard Reithinger, et al.
Scientific Reports|July 9, 2022
Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversionNicholas S Giroux, Shengli Ding, Micah T McClain, et al.
Scientific Reports|April 20, 2023
Author Correction: Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversionNicholas S Giroux, Shengli Ding, Micah T McClain, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trialsJill Whitley, Christopher Zwolinski, Christian Denis, et al.
Pageof 18